Evolent reports Q3 2026 revenue of $725M
Evolent Health announced third quarter 2026 results with revenue increasing 51.4% to $725.3 million, driven by strong demand for complex care solutions. The company also reported seven new or expanded revenue agreements for 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed